UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043614
Receipt number R000049799
Scientific Title Effectiveness of Occupation-Based Intervention for Brain Tumor Patients
Date of disclosure of the study information 2021/03/25
Last modified on 2023/01/08 22:05:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of Occupation-Based Intervention for Brain Tumor Patients

Acronym

Effectiveness of Occupation-Based Intervention for Brain Tumor Patients

Scientific Title

Effectiveness of Occupation-Based Intervention for Brain Tumor Patients

Scientific Title:Acronym

Effectiveness of Occupation-Based Intervention for Brain Tumor Patients

Region

Japan


Condition

Condition

Brain tumor

Classification by specialty

Neurosurgery Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether occupational therapy based on OBI for patients with brain tumors is effective in maintaining and improving the QOL of patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II,III


Assessment

Primary outcomes

As a primary outcome, QOL's The European Organization for Research and Treatment of Cancer QLQ-C30 will be evaluated before and during the final intervention.

Key secondary outcomes

Secondary outcomes include the National Institutes of Health Stroke Scale, Brunnstrom stage, grip strength, and knee extension muscle strength. We will implement a walking speed of 10m as a walking ability. The Mini Mental State Examination will be conducted as a cognitive function. Functional independence measure and Barthel index are implemented as ADL ability. As a mental function, we will carry out the Hospital Anxiety and Depression Scale. The above evaluation will be performed before the intervention and at the time of the final intervention.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

Create a list of patients who will be hospitalized for brain tumor resection and undergo rehabilitation intervention from April 1, 2021 to January 31, 2022. Explain the study to patients who meet the eligibility criteria and obtain their consent. Initial evaluation is performed before surgery and intervention is started after surgery. In the occupation-based intervention implementation group, clear goals are set using work selection decision support software, and work-based interventions are implemented. The intervention is 60 minutes, two-thirds perform meaningful work interventions based on life history, and one-third perform functional exercises. The frequency of intervention is 5 times a week.

Interventions/Control_2

From January 1, 2020 to March 31, 2021, we will prepare a list of patients who will be hospitalized for the purpose of brain tumor resection and will undergo rehabilitation intervention. Explain the study to patients who meet the eligibility criteria and obtain their consent. Initial evaluation is performed before surgery and intervention is started after surgery. In the occupation-based intervention non-execution group, two-thirds practiced functions and one-third performed activities of daily living, without using goal setting tools such as work selection decision support software and Canadian Occupational Performance Measure. Instrumental Activities of Daily Living Practice. The frequency of intervention is 5 times a week.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The selection criteria were cases in which consent was obtained for participation in this study, cases diagnosed as brain tumors, cases in which rehabilitation intervention was performed after brain tumor removal, cases over 20 years old, and cases with Mini Mental Stage Examination 24 points or more.

Key exclusion criteria

Exclusion criteria include cases with a history of congenital disorders or diseases in the central nervous system, cases with a Mini Mental Stage Examination of 23 points or less, cases in which the consent of the patient was not obtained, and other cases in which the principal investigator is inappropriate as a subject. The case was judged to be.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Ito
Middle name
Last name Syun

Organization

Shinshu University Hospital

Division name

Rehabilitation department

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto City, Nagano Prefecture

TEL

0263-37-2836

Email

itosyun@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Ito
Middle name
Last name Syun

Organization

Shinshu University Hospital

Division name

Rehabilitation department

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto City, Nagano Prefecture

TEL

0263-37-2836

Homepage URL


Email

itosyun@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Occupational Therapists Association

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University Hospital

Address

3-1-1 Asahi, Matsumoto City, Nagano Prefecture

Tel

0263-37-2836

Email

itosyun@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

信州大学医学部附属病院(長野県)


Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

42

Results

Post-intervention comparison of the intervention and control groups showed significant improvement in HADS-A items in the intervention group (p <0.05). The pre- and post-intervention comparison of the control group showed significant worsening in the 10-meter walk (maximal) after the intervention (p <0.05). Pre- and post-intervention comparisons of the intervention group showed significant worsening in overall quality of life, insomnia, and HADS-D after the intervention (p < 0.05).

Results date posted

2023 Year 01 Month 08 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The intervention group consisted of 1 male and 5 females. the mean age was 42.8years, and the who grade was 1.8. The mean hospital stay was 17.3 days, and the mean postoperative stay was 10.3days.
The gender of the control group consisted of 2 males and 4 females. The mean age was 54.3years, and the who grade was 2.8. The mean hospital stay was 17.8 days, and the mean postoperative stay was 11.2days.

Participant flow

The subjects were patients who had been diagnosed with brain tumors and had undergone tumor resection, and were hospitalized between January 1, 2020 and March 31, 2021. In the intervention group, occupational therapists interviewed patients using ADOC 4 days after surgery, when their general condition had settled down, to identify occupational therapy goals. In the interview, the subjects were asked about "what they want to be able to do," "what they want to try newly," "what they have trouble doing," "what they are worried about," "what they want to do," and "what they want to do. The subjects were asked to select important tasks applicable to "things they want to be able to do," "things they want to try newly," "things they are having trouble doing," "things they are worried about," and "things they need to be able to do. Then, two-thirds of the participants received intervention for the meaningful tasks selected by ADOC, and one-third received functional practice associated with the tasks selected by ADOC. For example, when the ADOC-selected task was cooking, a situation was set up that simulated the home environment, and the participants practiced making items that they frequently made at home for the number of family members. At the final intervention, the participants were given specific written instructions for the tasks selected in the goal setting.
In the control group, after assessment of motor and cognitive functions, two-thirds of the participants practiced functions, and one-third practiced Activities of Daily Living (ADL) and Instrumental Activities of Daily Living. Goal-setting tools such as ADOC and COPM were not used. Functional exercises included aerobic exercise, strength exercises, and balance exercises (modified Borg Scale score 4 or higher).

Adverse events


Outcome measures

Patient characteristics such as gender, age, disease, grade, length of hospitalization, and postoperative period were extracted from the medical records. Muscle strength was assessed by grip strength, which was measured using a Jaymer-type hydraulic grip strength meter. Walking speed was assessed using the 10 meter walking test (10MWT). Participants were instructed to walk as fast and as comfortably as possible without running on a 10 m sidewalk in a clinical setting. Cognitive function was assessed using the MMSE-J. ADL was assessed using the Functional Independence Measure (hereafter, FIM). Mental function was assessed using the Hospital Anxiety and Depression Scale (HADS), which can evaluate anxiety (HADS-A), depression (HADS-D), and the sum of anxiety and depression scores (HADS-A+D). It consists of 14 items: 7 items related to depression and 7 items related to anxiety. Quality of life was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30 {EORTC QLQ-C30 (version 3.0)} ( It consists of 30 questions and can assess overall quality of life and functional and symptom scales. The functional scale is divided into physical, role, cognitive, emotional, and social items. The symptom scale is divided into nausea and vomiting, fatigue, dyspnea, pain, sleep disturbance, anorexia, diarrhea, and economy. Higher scores on the Overall Quality of Life and Functioning scales indicate a better quality of life, while higher scores on the Symptom Scale indicate more severe symptoms.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 03 Month 31 Day

Date of IRB

2021 Year 02 Month 12 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2023 Year 01 Month 31 Day

Date of closure to data entry

2023 Year 01 Month 31 Day

Date trial data considered complete

2023 Year 01 Month 31 Day

Date analysis concluded

2023 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2021 Year 03 Month 15 Day

Last modified on

2023 Year 01 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049799


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name